Auro Viswabandya

18PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersCardiovascular medicine and haematology not elsewhere classifiedCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 29, 2026
Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic Transplantation.

|Feb 04, 2026
PTCy versus ATG in HLA-matched sibling donor allogeneic transplantation: Comment on: Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working Party.

Nihar Desai, Auro Viswabandya

|Oct 24, 2025
Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival.

Sergio Rodriguez-Rodriguez, Nihar Desai, Christopher Lemieux

|Jul 21, 2025
Recurrent Hypoglycemia during Sorafenib Maintenance Post-Allogeneic Hematopoietic Stem Cell Transplantation.

Nihar Desai, Auro Viswabandya

|Jun 03, 2025
Prolonged length of stay in high-risk patients undergoing allogeneic stem cell transplantation: a call to action for addressing healthcare challenges.

Ayman Sayyed, Igor Novitzky-Basso, Mats Remberger

|Nov 20, 2024
PTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantation.

Nihar Desai, Majed Altareb, Mats Remberger

Pageof 3

Frequent Collaborators

11 joint publications

Arjun Law

11 joint publications

Rajat Kumar

7 joint publications

Igor Novitzky-Basso

7 joint publications

Ivan Pasic